KROS
Keros Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Keros Therapeutics (KROS) Stock: Buy, Sell, or Hold?
$9.54
+0.21 (+2.25%)
▲
5d:
-11.91%
30d:
-15.05%
90d:
-10.51%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect KROS Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (96%)
Quality Score
55/100
Position
OVERSOLD
30-Day Fair Range
$10.13 – $11.67
Position: OVERSOLD
Forward P/E & Valuation
-1.4x
Next 12M consensus est.
Wall Street Target
$19.83
+107.9% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$8.98 / $11.88
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: KROS is down 11.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When KROS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: KROS is currently trading at $9.54, which is considered oversold relative to its 30-day fair value range of $10.13 to $11.67.
Technical Outlook: Technically, KROS is showing sideways momentum. Immediate support is located at $8.98, while resistance sits at $11.88.
Market Sentiment: KROS scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $19.83 (+107.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KROS is showing sideways momentum. Immediate support is located at $8.98, while resistance sits at $11.88.
Market Sentiment: KROS scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $19.83 (+107.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.13 -
$11.67
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.8%
Trading Range & Key Levels
30-Day Trading Range
$10.13 -
$11.67
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.72
(7.5%)
Support Level
$8.98
Resistance Level
$11.88
Current Trend
Sideways
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding KROS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 107.9% below Wall St target ($19.83)
- BULLISH: Bottoming setup score 60/100 — corrected, stabilizing, and turning up
- WARNING: Recommendation downgraded due to -11.9% 5-day decline - wait for stabilization
Fundamental Context
Forward P/E (Next Year Est.)
-1.44
Wall Street Target
$19.83
(+107.9%)
Revenue Growth (YoY)
180.5%
Profit Margin
-151.4%
Share KROS Analysis
Share this live KROS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (KROS)
Neutral
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jan 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on StockTwits regarding an upcoming presentation by Takeda for $KROS, suggesting potential milestone achievement.
Key Retail Themes:
Upcoming presentation by Takeda
Potential milestone achievement for $KROS
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:59 AM ET
Data refreshes hourly during market hours. Next update: 3:59 AM
Data refreshes hourly during market hours. Next update: 3:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KROS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$107 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
Advanced KROS Option Strategies
Professional options setups generated by AI based on today's KROS price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive KROS Research Pages
